Needham, MA, United States of America

Anna Berkenblit

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Anna Berkenblit

Introduction

Anna Berkenblit is an accomplished inventor based in Needham, Massachusetts, known for her significant contributions to the field of medical research, particularly in cancer therapies. With a total of three patents to her name, Berkenblit's work has been instrumental in developing innovative treatment options for patients with specific types of cancers.

Latest Patents

Among Berkenblit's latest patents is a groundbreaking treatment regimen utilizing neratinib for breast cancer. This patent describes an extended regimen intended for patients with HER-2/neu overexpressed or amplified cancers, involving the delivery of neratinib therapy following surgical and adjuvant treatments. The regimen can be maintained for a period ranging from twelve months to five years, improving patient outcomes. Additionally, she has developed a method for the anti-tumor activity of CCI-779 in treating papillary renal cell cancer. This invention outlines the method or use of CCI-779 specifically in addressing this type of cancer, offering a promising therapy option for affected patients.

Career Highlights

Anna Berkenblit currently works at Wyeth, which is a leading biopharmaceutical company focused on developing innovative solutions to address significant health challenges. Her work at Wyeth underscores her dedication to advancing cancer treatment and enhancing patient care.

Collaborations

Throughout her career, Berkenblit has collaborated with notable professionals, including Jay Marshall Feingold and Christina Marie Coughlin. These collaborations have played a crucial role in fostering innovative ideas and pushing the boundaries of current cancer research.

Conclusion

Anna Berkenblit's contributions to the medical field exemplify the impact of innovative thinking in the quest for effective cancer therapies. With her ongoing work and collaborations, she continues to make significant strides in improving treatment options available for patients, ensuring her legacy as an influential inventor in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…